Complete Care Southlake

CLIA Laboratory Citation Details

3
Total Citations
20
Total Deficiencyies
8
Unique D-Tags
CMS Certification Number 45D2082398
Address 321 W Southlake Blvd Suite 140, Southlake, TX, 76092
City Southlake
State TX
Zip Code76092
Phone(817) 809-2089

Citation History (3 surveys)

Survey - May 14, 2024

Survey Type: Standard

Survey Event ID: MUMO11

Deficiency Tags: D5401 D5401 D0000

Summary:

Summary Statement of Deficiencies D0000 The laboratory was found to be in substantial compliance with CLIA regulations 42 CFR Part 493. Standard level deficiencies were cited. D5401 PROCEDURE MANUAL CFR(s): 493.1251(a) A written procedures manual for all tests, assays, and examinations performed by the laboratory must be available to, and followed by, laboratory personnel. Textbooks may supplement but not replace the laboratory's written procedures for testing or examining specimens. This STANDARD is not met as evidenced by: Based on review of the laboratory's policies, calibration verification records from 2023 for the Triage analyzer , review of patient test volumes, and staff interview, the laboratory failed to have documentation of performing calibration verification on the Triage analyzer every six months for two of two events in 2023. Findings include: 1. Review of the laboratory's policies "Laboratory Procedure Triage Cardiac Panel" and "Laboratory Procedure Triage D Dimer", approved by the laboratory director on 11/01 /2023 determined : "Verification of Linearity and Precision B. Verification Frequency When a new analyzer is put into use and every 6 months after this date." Tests performed on the Triage Cardiac Panel are: a) CK-MB (Creatinine Kinase - Myocardial Band) b) Troponin-I 2. The laboratory was asked to provide documentation of performing calibration verification for Cardiac Panel and D-Dimer cartridges on the Triage analyzer in 2023. No documentation was provided. 1. Review of patient test volumes for the Triage analyzer in 2023 revealed the following: a) Cardiac Panel: 207 tests b) D-Dimer: 89 tests 2. Technical Consultant-1 and Technical Consultant-2 (as listed on the CMS-209 form) confirmed the findings during an interview on 05/14/2024 at 1130 hours in the office. Key: CMS - Centers for Medicare and Medicaid Services Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - July 12, 2022

Survey Type: Standard

Survey Event ID: C2D111

Deficiency Tags: D5209 D5209 D5411 D5417 D0000 D5411 D5417

Summary:

Summary Statement of Deficiencies D0000 Laboratory representatives were present at the entrance conference. The survey process was discussed. An opportunity for questions and comments was given. The exit conference was held with the laboratory representatives. The laboratory was found to be in substantial compliance for the specialties/subspecialties for which it was surveyed. The standard level deficiencies cited were discussed. The process for submitting the corrections was explained. CMS form 2567 will be emailed from the Texas Health and Human Services Commission, Health Facility Compliance Arlington Group. Note: The CMS-2567 (Statement of Deficiencies) is an official, legal document. All information must remain unchanged except for entering the

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - January 28, 2021

Survey Type: Standard

Survey Event ID: RI2511

Deficiency Tags: D0000 D5411 D0000 D5411 D5429 D5781 D6046 D5429 D5781 D6046

Summary:

Summary Statement of Deficiencies D0000 An entrance conference was held with laboratory representatives. The survey process was discussed and survey forms were provided. An opportunity for questions and comments was given. Noted deficiencies and plans of correction were discussed with the laboratory representatives at the exit conference. The laboratory representatives were given an opportunity to provide evidence of compliance with the noted deficiencies, and no such evidence was provided prior to survey exit. The facility was found to be in COMPLIANCE with applicable Conditions of Participation in the CLIA program, and recertification is recommended. Note: The CMS-2567 (Statement of Deficiencies) is an official, legal document. All information must remain unchanged except for entering the

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access